New York Assemblymember Amy Paulin (D) plans to refile her psilocybin legalization bill for the January 2025 legislative session after the measure failed to advance in 2024.
Dried psilocybin mushrooms.
The proposed legislation, titled Assembly Bill 10375 during this year’s session, was introduced in May 2024. The measure sought to establish a comprehensive framework for the “regulated adult use, support services, and cultivation of psilocybin-containing fungi.” Despite significant interest, the bill did not progress through the legislature this year.
Paulin’s bill outlines a system for licensing and regulating psilocybin therapy, allowing qualified adults to use the substance under the supervision of licensed healthcare professionals in designated service centers. The measure would also remove psilocybin from the state’s list of controlled substances.
The legislation also proposes a broad definition of “licensed healthcare provider,” enabling professionals across multiple disciplines—including medicine, social work, and mental health counseling—to facilitate psilocybin-assisted therapy programs. The list of qualifying conditions for psilocybin treatment was similarly expansive, addressing issues like chronic pain, end-of-life distress, and more, with flexibility for conditions beyond those explicitly listed.
Paulin has expressed her commitment to advancing this legislation in the upcoming session, emphasizing its potential to provide innovative treatments for individuals facing severe health challenges. The new bill is expected to have essentially the same language as AB 10375.
